Tech Company Financing Transactions
Neuronascent Funding Round
On 3/18/2015, Neuronascent raised $1.2 million in funding from private investors.
Transaction Overview
Company Name
Announced On
3/18/2015
Transaction Type
Venture Equity
Amount
$1,200,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. A portion of the total amount sold consists of a warrant which has been issued but its effectiveness is subject to certain conditions which have not yet been met. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
6030 Day Break Cir. A150 - PMB244
Clarksville, MD 21029
USA
Clarksville, MD 21029
USA
Phone
Website
Email Address
Overview
Neuronascent is focused on the discovery and development of therapies for Alzheimer's disease, stroke and depression based on the science of neurogenesis that.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Judith Kelleher
Chief Operating Officer
Kenneth Narducy
Browse more venture capital transactions:
Prev: 3/18/2015: Audvisor venture capital transaction
Next: 3/18/2015: Twin Prime venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs